Evidence map›Paper›PMID 41439024›Full record

ArticleComputational and structural biotechnology journal2025

Jeerakit Kerdsiri, Kowit Hengphasatporn, Tasana Pitaksuteepong, Nitra Nuengchamnong, Aphinya Suroengrit, Phumbodin Chupinidsakulwong, Yasuteru Shigeta, Parvapan Bhattarakosol, Siwaporn Boonyasuppayakorn, Neti Waranuch

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeerakit KerdsiriCosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Kowit HengphasatpornCenter for Computational Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Tasana PitaksuteepongCosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Nitra NuengchamnongScience Laboratory Center, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand.
Aphinya SuroengritCenter of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Phumbodin ChupinidsakulwongCosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Yasuteru ShigetaCenter for Computational Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Parvapan BhattarakosolCenter of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Siwaporn BoonyasuppayakornCenter of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Neti WaranuchCosmetics and Natural Products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, caused by the SARS-CoV-2 virus. This infectious disease significantly targets the upper and lower respiratory tracts of humans and animals. The mechanisms of SARS-CoV-2 infection are crucially mediated by specific viral proteins, such as the spike protein, as well as various enzymes, including proteases and transferases, and host proteins, including the ACE2 receptor. These proteins facilitate viral attachment and viral replication. This study aimed to identify the potential candidate compounds from

Indexed as

Andrographis paniculataBioassay-guided fractionationCOVID-19Drug discoveryLC-ESI-QTOF-MS/MSMolecular dockingSARS-CoV-2

Identifiers

PMID41439024
PMCPMC12720350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.